Saglik Bilimleri Universitesi
sbu.edu.trLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
532
Active
156
Phase 3
1
Total enrollment
51,567
Pipeline matrix
Showing 14 of 14 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Remifentanil | — | — | — | — | — | 3 | |
| control group | — | — | — | — | — | 2 | |
| Bupivacaine | — | — | — | — | — | 2 | |
| Normal Saline | — | — | — | — | — | 2 | |
| Dexmedetomidine | — | — | — | — | — | 2 | |
| Hyaluronic Acid (0.8%) - Applied over CTG before flap closure (Test group only). | — | — | — | — | — | 1 | |
| Experimental Group | — | — | — | — | — | 1 | |
| Aflibercept biosimilar | — | — | — | — | — | 1 | |
| N2O | — | — | — | — | — | 1 | |
| Fentanyl | — | — | — | — | — | 1 | |
| Gene Expression Analysis | — | — | — | — | — | 1 | |
| Midazolam | — | — | — | — | — | 1 | |
| Nicardipine | — | — | — | — | — | 1 | |
| Salbutamol | — | — | — | — | — | 1 |
Next readouts
- 2024-09-30
- 2025-06-01
- 2025-06-15
- 2026-01-01
- 2026-03-01
- 2026-05-14
- 2026-06-20
- 2026-07-01
- 2026-08-01
Top conditions
- Anxiety26
- Pain25
- Quality of Life13
- Breast Cancer11
- Periodontitis8
- Nursing Caries8
- Stress7
- Telerehabilitation7
Frequently asked questions about Saglik Bilimleri Universitesi
- How many clinical trials does Saglik Bilimleri Universitesi have on ClinicalTrials.gov?
- Saglik Bilimleri Universitesi is listed as the lead sponsor on 532 clinical trials in ClinicalTrials.gov, 156 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Saglik Bilimleri Universitesi's trials are in Phase 3?
- 1 of Saglik Bilimleri Universitesi's trials are in Phase 3, spread across 14 active drug programs.
- What therapeutic areas does Saglik Bilimleri Universitesi focus on?
- Saglik Bilimleri Universitesi's most-studied conditions on ClinicalTrials.gov are Anxiety, Pain, Quality of Life, Breast Cancer, Periodontitis.
- When are Saglik Bilimleri Universitesi's next clinical trial readouts?
- Saglik Bilimleri Universitesi has 9 upcoming primary-completion readouts tracked here; the soonest is “Efficacy of Remifentanil in Preventing Emergence Agitation”, expected around 2024-09-30.